These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 3155585

  • 1. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
    Amin DK, Shah PK, Shellock FG, Hulse S, Brandon G, Spangenberg R, Swan HJ.
    Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585
    [Abstract] [Full Text] [Related]

  • 2. Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
    Likoff MJ, Ulrich S, Hakki A, Iskandrian AS.
    Am J Cardiol; 1986 Jun 01; 57(15):1328-34. PubMed ID: 2940855
    [Abstract] [Full Text] [Related]

  • 3. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
    Kereiakes D, Chatterjee K, Parmley WW, Atherton B, Curran D, Kereiakes A, Spangenberg R.
    J Am Coll Cardiol; 1984 Nov 01; 4(5):884-9. PubMed ID: 6238076
    [Abstract] [Full Text] [Related]

  • 4. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
    Uretsky BF, Generalovich T, Reddy PS, Salerni R, Valdes AM, Spangenberg RB, Lang JF, Okerholm RA.
    Am J Cardiol; 1984 Aug 01; 54(3):357-62. PubMed ID: 6235735
    [Abstract] [Full Text] [Related]

  • 5. Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
    Petein M, Levine TB, Cohn JN.
    J Am Coll Cardiol; 1984 Aug 01; 4(2):364-71. PubMed ID: 6736478
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
    Installé E, Gonzalez M, Jacquemart JL, Collard P, Roulette F, Pourbaix S, Tremouroux J.
    Am J Cardiol; 1987 Aug 14; 60(5):46C-52C. PubMed ID: 2956868
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
    Durrieu C, Rochoux G, Coste P, Le Goff G, Besse P.
    Arch Mal Coeur Vaiss; 1990 Sep 14; 83 Spec No 3():43-50. PubMed ID: 2147834
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure.
    Uretsky BF, Generalovich T, Verbalis JG, Valdes AM, Reddy PS.
    Am J Cardiol; 1986 Jul 01; 58(1):110-6. PubMed ID: 2942027
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    Mager G, Klocke RK, Kux A, Höpp HW, Hilger HH.
    Am Heart J; 1991 Jun 01; 121(6 Pt 2):1974-83. PubMed ID: 1852090
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.